Bio-Rad Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bio-Rad Laboratories using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-29 | $2.26 | $2.08 | 8.65 % |
| Q2 | 2025-07-31 | $2.61 | $1.82 | 43.4 % |
| Q1 | 2025-05-01 | $2.54 | $1.78 | 42.7 % |
| Q4 | 2025-02-13 | $2.90 | $2.88 | 0.69 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-29 | $653.00M | $651.35M | 0.25 % |
| Q2 | 2025-07-31 | $651.60M | $612.59M | 6.37 % |
| Q1 | 2025-05-01 | $585.40M | $573.23M | 2.12 % |
| Q4 | 2025-02-13 | $667.50M | $679.75M | -1.80 % |
Bio-Rad Laboratories (BIO) is scheduled to report earnings on February 12, 2026. The last reported earnings were for reported on October 29, 2025 for Q3.
The Actual EPS was $2.26, which beat the estimate of $2.08.
The Actual Revenue was $653M, which beat the estimate of $651.3M.
Browse earnings estimates, EPS, and revenue on all stocks.